Learn more about the challenges of this "silent" liver disease along with therapeutic strategies to accelerate both clinical and regulatory efforts for this critical unmet medical need.
This is a golden age for infectious disease clinical trials. Novel technologies give us a deeper understanding of the molecular mechanisms of disease states, and the body's responses to them. Increased access to a wider global patient population and new tools to visualize large data sets enable new insights into how diseases spread.
The human immune system plays a pivotal role in conferring protective immunity to pathogenic microorganisms and cancer while its hyper-activation can result in serious inflammatory conditions such as autoimmunity.
Join our market access experts as they discuss the changing landscape and the role of a market access field team to support a drug's launch and lifecycle.